Orexo AB (publ) ORXOY
Set alert
0.66 USD 0.00 +0.03%
At close · Oct 30
0.6642 Day range 0.6642
0.492 52-week range 3.00
- YTD
- -74.45%
- 1 year
- -77.79%
- Open
- 0.6642
- Prev close
- 0.664
- Mkt cap
- 23.33M
- Vol
- 100
- Avg vol
- 218
- EPS
- -1.35
- P/E
- 0.00
More statistics
- Low
- 0.6642
- High
- 0.6642
2Y chart
Signals (32)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 17, 2026 | 3 months ago |
| RSI: Oversold | Jul 17, 2026 | 3 months ago |
| RSI: Overbought | Jul 16, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 17, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| MACD: Buy Signal | May 20, 2026 | 5 months ago |
| SMA: Bearish | Apr 30, 2026 | 6 months ago |
| RSI: Oversold | Apr 30, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 2, 2026 | 7 months ago |
| RSI: Overbought | Mar 11, 2026 | 7 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 17, 2025 | 10 months ago |
| RSI: Oversold | Dec 17, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 24, 2025 | 11 months ago |
| RSI: Oversold | Nov 7, 2025 | 12 months ago |
| SMA: Bearish | Nov 5, 2025 | 12 months ago |
Newest 20 of 32.
News
- Orexo AB (publ) (ORXOY) Q3 2026 Earnings Call Transcript
- Orexo reaches non-binding agreement in principle to settle investigation by US Department of Justice
- Orexo reaches non-binding agreement in principle to settle investigation by US Department of Justice
- Orexo AB (publ) (ORXOY) Q2 2026 Earnings Call Transcript
- Orexo AB (publ) (ORXOY) Q1 2026 Earnings Call Transcript
- Invitation & Agenda: Orexo R&D Day on March 24
- Invitation & Agenda: Orexo R&D Day on March 24
- Orexo changes the organizational structure and management team to increase focus on development of new products
- Orexo AB (publ) (ORXOY) Q4 2025 Earnings Call Transcript
- Orexo AB (publ) (ORXOY) Discusses Divestment of US Rights to Zubsolv and Transition Agreement with Dexcel Pharma Transcript
Your note
Sign in to keep a note on ORXOY — it syncs with the Stock Master app.